steroids and oestrogen precursors which may affect the onset of labour. The cumulative percentage according to weeks of gestational age of boys born in a given birthweight category was more similar to the cumulative percentage of girls born in the adjacent lighter birthweight category than the cumulative percentage born in the same birthweight category. Thus at any given gestational age there appeared to be a fetal weight which was, by itself, able to trigger the spontaneous onset of labour. Alternatively, specific hormonal differences between male and female fetuses, such as increased male testosterone concentrations,' may have been responsible. Although we do not know why girls are more likely to be induced, it may be because they are more likely to remain undelivered after term. Female babies are more likely to present by the breech and are therefore over-represented among breech births. Easier delivery due to lower birth weight seems not to be a factor. When the fetal presentation is cephalic, however, female babies are much more likely to be delivered spontaneously whereas male babies are more likely to deliver either by forceps or by caesarean section. There has in recent years been a policy of operative or instrumental delivery in preterm births, but this is not the reason for the higher forceps and caesarean section rate in boys, although they do deliver preterm more often. Cephalopelvic disproportion may occur more often because of the greater weight of male babies or the male fetal hormonal contribution to the progress of labour may be less effective than the female, thus resulting in maternal uterine dysfunction. Furthermore, male babies may show fetal distress in labour more often or more severely than female. This seems the most likely explanation and is consistent with the fact that neonatal mortality from difficult labour is higher in boys,7 as is stillbirth from difficult labour. This cause of death showed a higher sex ratio than any other cause of stillbirth. In a survey of 461 women routinely attending family planning clinics those taking oral contraceptives had significantly higher mean systolic and diastolic blood pressures than those using non-hormonal contraception. There appeared to be a dose-response relation of blood pressure to the progestogen component of two oral contraceptives with an identical 30 stg ethinyloestradiol component. This supports the idea that the progestogen as well as the oestrogen component has an aetiological role in the rise in blood pressure. There was a significant correlation of blood pressure with duration of current use of oral contraceptive but not with total duration of use. There was also a significant negative correlation of blood pressure with time since oral contraceptives were last taken, and women who had stopped using oral contraceptives over a month previously had similar blood pressures to those who had never taken them. In women taking oral contraceptives those who had either a history of hypertension in pregnancy or a family history of hypertension had significantly higher mean blood pressures than those who did not. Both systolic and diastolic blood pressures correlated independently with weight and body mass index, but controlling for the effect of this and age did not affect the above relations. No significant differences in mean blood pressures were found between different ethnic groups, and there was no relaIntroduction It is generally accepted from cross-sectional and longitudinal studies that use of oral hormonal contraceptives is aetiologically associated with a rise in blood pressure.'-8 The precise nature of this relation, however, is not clear: neither the component in the oral contraceptive responsible nor any groups who might be most at risk of a rise in blood pressure have been convincingly demonstrated. Most studies were done when oral contraceptives with an oestrogen dose of 50 ,tg or more were commonly prescribed. The oestrogen component has been associated with increased morbidity, particularly from vascular events, and is believed to be the component responsible for the rise in blood pressure. After a recommendation in 1969 by the Committee of Safety of Medicines the oestrogen dose in oral contraceptives was lowered, and in the past few years oral contraceptives containing 30 ,tg oestrogen have been routinely preferred. One study,6 however, found that women using contraceptives containing 30 Ftg oestrogen had similar blood pressures to those using contraceptives containing 50 Ftg oestrogen, and the authors suggested that the progestogenic component might be important in raised blood pressure, though another study did not support this.7
There is little evidence that there are any subgroups who might be particularly susceptible to the hypertensive effect of oral contraceptives, though possibly women who have a history of phase five (disappearance of sounds). The mean of the two values was used for analysis. Height and weight were measured with the subjects wearing light clothing without shoes. Blood pressure was recorded by one observer trained in blood pressure measurements using a standard tape recording. 9 Results BLOOD PRESSURE, AGE, WEIGHT, AND CONTRACEPTIVE USE The women were divided into two age groups-those aged under 35 and those aged 35 and over-because of differences in prescribing policy for oral contraception in women over 35. Women under 35 using oral contraception had significantly higher mean systolic and diastolic blood pressures than those using non-hormonal forms of contraception (table I) . Mean ages were similar (24-2 years in those taking oral contraception, 25-3 years in those using non-hormonal contraception). In the group aged 35 and over no significant differences in blood pressure were found; this was probably due to selection differences (see below). Overall, there was a significant correlation of both systolic and diastolic pressures with weight (systolic pressure r=0-34, p<0-001; diastolic pressure r = 0-37, p < 0-001), and partial correlations of systolic blood pressure with weight controlling for diastolic pressure and of diastolic pressure with weight controlling for systolic pressure were both significant (p < 0-002), suggesting that both pressures have independent relations with weight. Correlation coefficients were no better for body mass index than for weight alone, so subsequent analyses were confined to weight. There were also significant correlations of pulse rate with both systolic and diastolic pressures independent of weight. Adjustment for the effects of weight and pulse rate, however, did not account for the differences in blood pressure between those taking oral contraceptives and those using non-hormonal contraception, and There was no correlation of blood pressure with total duration of oral contraceptive use ever, but there was a significant correlation of both systolic and diastolic pressures with duration of current oral contraceptive use, and mean blood pressures were higher in those who had been taking oral contraceptives continuously for over 12 months compared with those who had been taking them for a month or less (table II) and those not using oral contraception. Blood pressures were also inversely correlated with time since oral contraceptives were last taken, and mean pressures of those who had stopped oral contraception more than a month previously were simi-
REASONS FOR CHOICE OF TYPE OF CONTRACEPTION
Women not using oral contraception and women who had changed the brand of oral contraceptive were asked for their reasons. Women who had never taken oral contraceptives because of hypertension had significantly higher mean systolic blood pressures than women who had stopped for reasons such as nausea, weight gain, or other medical conditions as well as women who had chosen non-hormonal methods for social reasons such as preference (table V) . Diastolic blood pressures were also higher, though not significantly so. Similarly, in the group using oral contraceptives women who had changed brands because of Vug levonorgestrel in Eugynon 30). The differences in mean blood pressure suggested a dose-response relation with the levonorgestrel component, and this was confirmed by analysis of variance. As discussed above, any selection bias would have minimised the association as women with high blood pressure were more likely to have been changed to the lower-dose Microgynon 30 from Eugynon 30. Thus the progestogen component in a low-dose oestrogen pill appears to have an appreciable effect on blood pressure.
This study showed a positive correlation between duration of current use of oral contraceptive and both systolic -and diastolic pressures. This is consistent with the finding of a longitudinal study that blood pressure increased with the time for which an oral contraceptive was taken.4 There was no relation -with total cumulative duration of oral contraceptive use. In a cross-sectional study a possible relation might be obscured by imperfect recall or history of total duration. It is unlikely, however, that accuracy of information should differ greatly between duration of current use and total duration of use. Another suggestion is that blood pressure may revert quite quickly during periods when contraceptive use is stopped. This is supported by the findings that women who had stopped taking oral contraceptives over a month previously had similar blood pressures to those who had never taken oral contraceptives and that both groups had lower blood pressures than current users. This implies that changes in blood pressure related to oral contraceptives are reversible in a short time and is again consistent with findings in some longitudinal studies,4 though not in others.", Two factors have been suggested that might make women susceptible to the blood-pressure raising effect of oral contraceptives-namely, a history of hypertension during pregnancy and a family history of hypertension. Most studies based on contraceptive clinics have found no significant relations,4 though in Kentucky highest systolic blood pressures were found in women who had had hypertension during pregnancy and were taking the oral contraceptive." In our study, among women using oral contraceptives those with either a history of hypertension during pregnancy or a family history of hypertension had significantly higher blood pressures than those without. In a cross-sectional survey it is impossible to say whether this observation was because this group had a higher basal pressure to begin with and experienced a similar rise in blood pressure while taking oral contraceptives to that in the group without such a history, or whether they experienced a greater rise in blood pressure while taking oral contraceptives: available evidence suggests the former. Women not using oral contraceptives who had had hypertension during pregnancy or had a family history of hypertension also had higher mean pressures than those who did not, though these differences were not significant in all-cases. This association is again unlikely to have been due to selection as any bias would probably have minimised the differences: women who have had hypertension during pregnancy or who have a family history of hypertension are more likely to be advised against oral contraception.
It may be hypothesised that groups who generally have higher distributions of blood pressure might be more susceptible to the hypertensive effects of oral contraceptives: studies in the United States found higher mean blood pressures in black compared with white adults, and in England in both factory workers13 and civil servants14 black men had higher mean blood pressures than white men. In our study, however, we found no differences between black and white women, though with the numbers available a 5 mm difference would have been significant. Few studies have examined the effect of different contraceptives on different ethnic groups. In 2676 black women attending a family planning clinic in Atlanta no significant differences in mean blood pressure were found between those using oral contraceptives and controls.15 16 In our study no significant differences in systolic blood pressure were detectable, and diastolic pressures were virtually identical. Though several explanations are possible-among them selection bias-there is no evidence that black women are particularly susceptible to the hypertensive effects of oral contraceptives. The differences in mean blood pressure documented here were small (around 5 mm Hg) but are of interest both in investigations of the aetiology and mechanisms of the rise in blood pressure and in terms of community impact. In a population in which a large proportion of healthy women are using oral contraceptives a small shift in the distribution of a risk factor may have a large impact on the community's overall burden of disease,"7 and there is no doubt that raised blood pressure is one of the major factors in morbidity and mortality in most societies. Though different effects of oral contraceptives cannot be considered in isolation, any oral contraceptive that can be shown to have a less adverse effect on blood pressure has implications for general prescribing policy. Within this context even the small but important differences in the progestogen contents of lowdose oestrogen pills may constitute differences in risk that, though insignificant to the individual, may be of considerable importance to the community. 
Case report
A 37-year-old company director presented with obesity and hypersomnolence. At the age of 9 years he had developed asthma, which had troubled him only intermittently. Eighteen months before presentation he had begun to experience disturbed sleep and hypersomnolence, and his weight had increased from 83 to 121 kg. He had consulted a neurologist and had since been taking amphetamines for a diagnosis of narcolepsy. His weight and symptoms had gradually increased. His main complaint was of irresistible somnolence, repeatedly falling asleep in the middle of important business meetings and while driving (crashing his car and injuring his daughter). He had never fallen asleep while standing up. His performance at work had deteriorated and the company was now in serious financial trouble. Associated features were morning headaches and loud snoring.
Examination disclosed no abnormality apart from drowsiness, obesity, a considerably deviated nasal septum partially blocking both nasal passages, and large tonsils. Spirometry showed moderate, reversible airways obstruction (forced expiratory volume in one second 2-1 1, vital capacity 4-8 1). Results of routine haematology, biochemistry, chest radiography, and electrocardiography were normal. Arterial oxygen tension was 11-5 kPa (86 mm Hg) and carbon dioxide tension 5-0 kPa (38 mm Hg). Overnight monitoring showed periods of obstructive apnoea during sleep producing swings of arterial oxygen saturation from 9400 to 720%. Arousal occurred only occasionally at the nadir of the drops in arterial oxygen saturation. Because of the relative mildness of his apnoea and his inability to lose weight protriptyline 60 mg/day was tried for one month but produced no benefit. Medroxyprogesterone acetate 50 mg nightly produced initial improvement followed by an appreciable decline. These drugs have been reported as beneficial in some cases of sleep apnoea syndrome.' Repeat overnight monitoring showed recurrent 40-second obstructive sleep apnoeas throughout the night, accompanied by arterial oxygen desaturation to 65%, arousal on each occasion, and heart rate oscillating between 85 and 125 beats/min.
Submucus resection and tonsillectomy were performed to reduce his upper airways resistance. He suffered obstructive apnoea at induction but intubation was accomplished without difficulty. No narcotics were used and the endotracheal tube was left in place for 18 hours postoperatively. Despite this he slept for long periods with intermittent nitrous oxide as the only analgesia. The next day he was fully alert; the hypersomnolence did not return.
Eighteen days later he was fully recovered. He had discovered business errors made in recent months, which he was trying to correct. Overnight monitoring showed no sleep apnoea, but snoring persisted. A tracing of arterial oxygen saturation showed small oscillations (< 2%). There were no recurrent arousals as before. In six weeks he lost 15 kg in weight; the snoring subsequently disappeared.
